Biocartis

Develops diagnostic systems to reduce the cost and improve the efficacy of personalised medical treatments

Total raised

€324M

€323,790,909

Funding rounds

Investors

distinct backers

Active since

2009-09

latest 2017-03

Funding by year

EUR raised per year

Medium confidence

Raise-next likelihood13

base rate 30% for Other

Exit likelihood28

base rate 12% (2+ rounds)

Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

9 rounds

Date	Stage	Amount	Investors
2017-04-01	Other	€80M	—	View deal →
2014-09-01	Series D+	€65M	—	View deal →
2014-06-01	Grant	€1.7M	—	View deal →
2013-11-01	Series D+	€30M	—	View deal →
2013-06-01	Grant	€2.1M	—	View deal →
2012-12-01	Series D+	€35M	—	View deal →
2011-11-01	Series C	€71M	—	View deal →
2010-04-01	Series B	€30M	Advent Venture Partners,Aescap,Offshore Investment	View deal →
2009-10-01	Series A	€10M	Advent Venture Partners,Aescap	View deal →

same sector or country